RecruitingOpen Angle GlaucomaPigmentary GlaucomaPseudoexfoliation Glaucoma
Standalone iStent Infinite and iDose TR for Management of Moderate to Severe Open Angle Glaucoma
Eligible age
18+ yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The Investigators will investigate the efficacy of combining the standalone iStent infinite and iDose that are minimally invasive surgical and drug depot options are a safe and effective alternative to filtering surgery for intraocuar pressure reduction in patients with medically uncontrolled open angle glaucoma.
Sponsor: Jonathon Myers
You may qualify if…
- ✓ Moderate to severe open angle glaucoma (including POAG, PG, and PXG)
- ✓ Open angle configuration (Shaffer grade ≥ 3), normal angle anatomy9
- ✓ Visual acuity HM or better
- ✓ VF MD -6dB or worse
- ✓ Failed medical therapy and/or laser treatment
- ✓ Incisional glaucoma surgery contemplated as next intervention
- ✓ Phakic or pseudophakic
You may not qualify if…
- ✕ Traumatic, uveitic, neovascular glaucoma, or angle closure glaucoma
- ✕ Previous incisional glaucoma surgery
- ✕ ALT; History of iridotomy, SLT, or micropulse laser trabeculoplasty within the prior 90 days
- ✕ Active ocular inflammation or edema, clinically significant corneal dystrophy
- ✕ Corneal or other pathology preventing accurate Goldmann applanation tonometry
Where it's recruiting
Pennsylvania
Philadelphia
Source: ClinicalTrials.gov · NCT07228221 · last updated 2025-11-14